Evaira 0.5mg Injection
Description
- Active substance: Eribulin.
- Class: Antineoplastic agents.
- Use: For advanced breast cancer or liposarcoma when other treatments have stopped working.
Important Information
- Allergies: Do not take if allergic to Eribulin or any other ingredients.
- Age restrictions: Not recommended for children and adolescents under 18 years.
- Medical history: Inform your doctor about any fever, infections, liver, or heart problems.
- Storage: Store at 25°C, in original packaging, protected from light and moisture, out of reach of children and pets.
Uses
- Advanced breast cancer.
- Liposarcoma.
Therapeutic Effects
- Stops the growth and spread of cancer cells by targeting microtubules.
- Prevents cell division without interfering with the shrinking phase.
- Causes tubulin to clump together, disrupting cell division.
- Blocks the cell cycle (G2/M phase) and triggers cell death through apoptosis.
Interaction with other drugs
- Inform your doctor about all medications, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
- Certain medications may interact with Evaira 0.5mg Injection and reduce effectiveness or cause undesirable side effects.
Safety Advices
- Pregnancy: Unsafe; may cause fetal harm.
- Breastfeeding: Not recommended; unknown if it passes through breast milk.
- Lungs: Can cause blood clots in the lungs and inflammation.
- Liver: Can affect liver function.
- Alcohol: Avoid or limit alcohol intake.
- Driving: Causes tiredness and dizziness, which may impair driving ability.
Side Effects
- Serious: Sepsis (severe infection), severe allergic reaction, serious skin conditions (Stevens-Johnson syndrome).
- Common: Decrease in white or red blood cells, tiredness or weakness, nausea, vomiting, constipation, diarrhea, numbness, tingling, fever, loss of appetite, weight loss, difficulty breathing, cough, pain in joints, muscles, and back, headache, hair loss.
Word of Advice
- Doctor will monitor liver function via blood tests and assess heart function.
- Reliable birth control recommended for women during treatment and after.
- Consult oncologist for dental treatment.
- Inform doctor if experiencing diarrhea, constipation, or loss of appetite.
FAQs
Q1: What is the most important information I should know while taking Evaira 0.5mg Injection? A1: Evaira 0.5mg Injection can cause serious adverse effects such as low white blood cell count, numbness, tingling, and pain in the hands and feet. Inform your physician immediately if you face any of these symptoms.
Q2: Does Evaira 0.5mg Injection cause infertility? A2: Yes, Evaira 0.5mg Injection causes infertility in men and women. Use effective birth control methods during treatment and for three weeks (females) and 14 weeks (males) after the final dose.
Q3: Is hair loss caused by Evaira 0.5mg Injection reversible? A3: Hair loss is a common side effect. It is reversible, but it depends on the severity and varies from person to person. Consult your doctor if you have severe hair loss.
Q4: Do I have to follow any special dietary requirements while taking Evaira 0.5mg Injection? A4: It depends on the severity of the disease condition. Check with your doctor if you have any nutrition concerns.
Q5: What should I do if I miss taking Evaira 0.5mg Injection? A5: Contact your healthcare provider and schedule your dosing immediately. Keep follow-ups on your next schedule.
Fact Box
- Molecule name: Eribulin.
- Therapeutic class: Anticancer.
- Pharmacological class: Monoclonal antibody-drug conjugate.
- Indications: Advanced breast cancer, liposarcoma.
- Dosage form: Injections.
- Habit forming: No.